2 October 2018 - Darryl Black was told he had just three months to live. That was ­almost four years ago.

The 62-year-old grandfather from Adelaide’s northern suburbs now wants others to access his lifesaving cancer treatment at an ­affordable price.

In early 2015, Mr Black became one of the first Australians to receive combination immunotherapy for advanced kidney cancer as part of a worldwide trial conducted by American pharmaceutical giant Bristol Myers Squibb.

Read The Australian article